Home/Filings/4/0000905148-25-000890
4//SEC Filing

Zago Wagner M. 4

Accession 0000905148-25-000890

CIK 0001559053other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:51 PM ET

Size

5.7 KB

Accession

0000905148-25-000890

Insider Transaction Report

Form 4
Period: 2025-03-05
Zago Wagner M.
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-03-05+107,500107,500 total
    Exercise: $14.95Exp: 2035-03-05Ordinary Shares (107,500 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 5, 2026, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Documents

1 file

Issuer

PROTHENA CORP PUBLIC LTD CO

CIK 0001559053

Entity typeother

Related Parties

1
  • filerCIK 0001708681

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:51 PM ET
Size
5.7 KB